(Q47341318)

14 January 2018

title

Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival (English)

1 reference

14 January 2018

main subject

cerebrospinal fluid

0 references

frontotemporal dementia

1 reference

1 reference

4

Henrik Zetterberg

1 reference

14 January 2018

3

Kaj Blennow

1 reference

14 January 2018

1

Tobias Skillbäck

1 reference

14 January 2018

Niklas Mattsson

series ordinal

2

object named as

Niklas Mattsson

1 reference

14 January 2018

publication date

6 February 2017

1 reference

14 January 2018

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

published in

1 reference

14 January 2018

volume

18

1 reference

14 January 2018

issue

5-6

1 reference

14 January 2018

page(s)

397-403

1 reference

14 January 2018

The frontotemporal dementia-motor neuron disease continuum

cites work

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Neurochemical aftermath of amateur boxing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

The epidemiology of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Factors predicting survival in ALS: a multicenter Italian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F21678421.2017.1281962

10.1080/21678421.2017.1281962

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018